Anzeige
Mehr »
Freitag, 03.10.2025 - Börsentäglich über 12.000 News
Starkes Upside-Potenzial: Wachstumsstory mit starken Gehalten und großem Explorationspotenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EGAA | ISIN: US5393193017 | Ticker-Symbol: 8640
NASDAQ
02.10.25 | 21:59
5,375 US-Dollar
+11,75 % +0,565
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
LIXTE BIOTECHNOLOGY HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
LIXTE BIOTECHNOLOGY HOLDINGS INC 5-Tage-Chart

Aktuelle News zur LIXTE BIOTECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.09.Lixte Biotechnology Holdings, Inc.: LIXTE's Bold Blueprint to Rewire Cancer's Master Switch and Redefine Its Own Future265BOCA RATON, FL / ACCESS Newswire / September 16, 2025 / For a small-cap biotech, the headlines often center on fundraising, partnerships, or meeting exchange requirements. But every so often, the spotlight...
► Artikel lesen
15.09.Lixte Biotechnology: Führungswechsel und strategische Neuausrichtung nach Kursrallye-
15.09.BOCA RATON - Lixte Biotechnology refreshes leadership and diversifies assets2
15.09.Lixte Biotechnology Holdings, Inc.: LIXTE Bio's Transformational Summer Marked by Leadership Updates, Scientific Progress, and Digital Treasury Strategy370BOCA RATON, FL / ACCESS Newswire / September 15, 2025 / For most small-cap biotechs, the summer months mean quiet trial work and the occasional conference slide deck. LIXTE Biotechnology Holdings (NASDAQ:LIXT)...
► Artikel lesen
11.09.LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report1
LIXTE BIOTECHNOLOGY Aktie jetzt für 0€ handeln
10.09.LIXTE Biotechnology makes $2.6M initial purchase of digital currency1
10.09.Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions87BOCA RATON, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced...
► Artikel lesen
05.09.24/7 Market News: LIXTE Holds the World's Only Clinical-Stage PP2A Inhibitor246Denver, Colorado--(Newsfile Corp. - September 5, 2025) - 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, underscores...
► Artikel lesen
03.09.Lixte Biotechnology appoints new CFO and board members1
25.08.24/7 Market News and LIXTE Biotechnology Holdings: 24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets6
19.08.LIXTE Biotechnology Holdings and 24/7 Market News: 24/7 Market News: LIXTE Biotechnology Spotlight- Revisiting the "Too Much of a Good Thing" Strategy for LB-1001
18.08.Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology Holdings Provides Corporate Update112-Completes Two Financings, Raising $6.5 Million- -Regains Compliance for Continued Listing on Nasdaq- -Announces Management Changes; Adds Two New Board Members- -Re-Establishes Scientific Advisory...
► Artikel lesen
15.08.LIXTE Biotechnology Holdings and 24/7 Market News: 24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025 1
14.08.LIXTE Biotechnology Holdings and 24/7 Market News: 24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 20251
13.08.Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology Holdings Updates Corporate Treasury Policy to Include Cryptocurrency123PASADENA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced...
► Artikel lesen
07.08.LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 10-Q, Quarterly Report1
21.07.LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report1
16.07.LIXTE Biotechnology regains Nasdaq compliance2
16.07.Lixte Biotechnology Holdings, Inc.: LIXTE Biotechnology Holdings Regains Compliance with Nasdaq's Continued Listing Requirements263PASADENA, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE" or the "Company") (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced...
► Artikel lesen
11.07.LIXTE BIOTECHNOLOGY HOLDINGS, INC. - 8-K, Current Report1
Weiter >>
39 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1